- €2.15bn
- €4.95bn
- €396.17m
- 34
- 66
- 65
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 287 | 293 | 341 | 365 | 396 |
Cost of Revenue | |||||
Gross Profit | 226 | 249 | 286 | 309 | 298 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 27.6 | 124 | 90.2 | 65.4 | 330 |
Operating Profit | 259 | 169 | 251 | 300 | 66.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 216 | 126 | 275 | 494 | -48 |
Provision for Income Taxes | |||||
Net Income After Taxes | 210 | 116 | 263 | 483 | -54.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 205 | 119 | 260 | 483 | -55.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 205 | 119 | 260 | 483 | -55.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 8.95 | 4.52 | 8.93 | 15.6 | -1.63 |
Dividends per Share |